Novartis

News

ASCO21: Gilead sets up first FDA okay for CAR-T in adult ALL...

Novartis' Kymriah has had the CAR-T therapy market for acute lymphoblastic leukaemia (ALL) to itself so far, but Gilead Sciences' Kite subsidiary is now looming in the rear view mirror – ar

News

ASCO21: Novartis' prostate cancer radiotherapy extends survi...

Novartis' big investment in radiopharmaceuticals for cancer seems to have paid off, after lead candidate 177Lu-PSMA-617 helped men with advanced prostate cancer and few treatment options li

News

Novartis halts three trials of Beovu eye drug on safety conc...

Prospects for Novartis' ophthalmology drug Beovu have taken another dive after the drugmaker reported toxicity issues in a new phase 3 trial in wet age-related macular degeneration (AMD).

Views & Analysis

How-cell-and-gene-therapies-are-transforming-the-pace-of-deal-making

New Cell & Gene Therapy Collective seeks to boost UK adoptio...

The UK has been a global leader in introducing cell and gene therapies that can potentially transform the lives of patients with debilitating diseases – but there are still many barriers to

News

NICE says yes to Novartis' multiple sclerosis therapy Kesimp...

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator.

News

Artifical intelegence DNA molecule. DNA is converted into a binary code. Concept binary code genome. Abstract technology science, concept artifical Dna, 3D illustration

Novartis expands in radio-oncology again with $1.3bn Artios ...

In its second licensing deal in the radio-oncology area in consecutive weeks, Novartis has agreed a $1.3 billion-plus alliance with UK biotech Artios Pharma to develop precision medicines f

ASCO21: Gilead sets up first FDA okay for CAR-T in adult ALL...

ASCO21: Novartis' prostate cancer radiotherapy extends survi...

Novartis halts three trials of Beovu eye drug on safety conc...

New Cell & Gene Therapy Collective seeks to boost UK adoptio...

NICE says yes to Novartis' multiple sclerosis therapy Kesimp...

Novartis expands in radio-oncology again with $1.3bn Artios ...

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Novartis

Editor's Picks